Black Seed Oil for Health & Longevity - Quick Reference Sheet
evipedia.ai ← Back

Black Seed Oil for Health & Longevity

Created on 06/25/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

Black seed oil is an inexpensive botanical that modestly improves cholesterol, blood sugar, blood pressure, and inflammation, with the largest gains in people whose starting values are already elevated. It is generally well tolerated, with mild digestive effects most common; combining it with blood-sugar or blood-pressure medication can lower those values too far. Promising but not yet definitive. (Full Review)

Protocol

Dose
500–1,000 mg, 1–2×/day
With meals; standardized to a defined thymoquinone amount
Form
Cold-pressed oil
Generally preferred over powder for cardiometabolic goals
Dosing schedule
Split twice daily
Favored over a single large dose given the short half-life
Time to effect
Blood lipids
By ~8 weeks
Lipid changes generally measurable by 8 weeks
Inflammatory markers
4–12 weeks
Metabolic and inflammatory markers typically shift over 4–12 weeks of consistent use
Blood glucose
By ~8 weeks
Glucose changes generally measurable by 8 weeks

Benefits

Contraindications
  • Pregnancy and breastfeeding
  • Scheduled surgery within ~2 weeks
  • Active liver disease or significant kidney impairment
  • Known seed allergy
    •
Key Interactions
  • Antidiabetic medications (metformin, sulfonylureas, insulin)
  • Antihypertensive medications (ACE inhibitors, calcium-channel blockers, diuretics)
  • Anticoagulants and antiplatelets (warfarin, clopidogrel, aspirin)
  • Drugs metabolized by liver CYP enzymes (cyclosporine, some statins, certain anticonvulsants)
  • OTC agents (ibuprofen, naproxen; sedatives, antihistamines)
  • Supplements with overlapping actions (berberine, cinnamon, chromium, garlic, CoQ10, omega-3s, fish oil, ginkgo, vitamin E)
    •

Risk & Side Effects

  • High:
  • Medium:
  • Low: Gastrointestinal upset; hypoglycemia or hypotension with additive agents; allergic & skin reactions
    •
  • Speculative: Hepatic or renal effects at high doses; bleeding risk & drug metabolism interference; effects in pregnancy
    •

Monitoring

Marker Target Why
LDL cholesterol < 100 mg/dL (lower if high CV risk) Primary lipid target
Total cholesterol / triglycerides TG < 100 mg/dL Tracks lipid response
HDL cholesterol > 50 mg/dL (women), > 40 mg/dL (men) Context for lipid ratio
Fasting glucose 75–90 mg/dL Glycemic response
HbA1c < 5.4% 3-month glucose average
hs-CRP < 1.0 mg/L Inflammation marker
Blood pressure < 120/80 mmHg Cardiovascular response
ALT / AST < 25 U/L (women), < 30 U/L (men) Safety at higher doses

Cadence: Baseline, then ~8–12 weeks after starting, then every 6–12 months; those on interacting medications check glucose and blood pressure at 1–2 and 4 weeks during initiation

Qualitative Assessment

  • Energy levels and daytime fatigue
  • Digestive comfort (to detect tolerability issues)
  • Joint comfort and any inflammatory symptoms
  • For users with asthma or allergies: breathing ease and symptom frequency
  • General sense of well-being
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.